Delivery Order SPE2DB24D1205-SPE2DB25FCWAT

Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Losartan Potassium 100 mg tablets. The contract has a ceiling value of $3,473.52 and is a delivery order with a firm fixed price. The contract has an ultimate completion date of September 10, 2024. This award does not utilize any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,105.81, is a delivery order for 4,563,927,418 units of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of March 12, 2024 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order worth $1,495.76, is for the supply of 4,566,599 units of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of December 4, 2024 and is a Firm Fixed Price agreement. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FA38Q, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,488,946 units of Losartan Potassium 100 mg tablets, with a ceiling value of $1,233.24. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,692,627 units of Losartan Potassium 100 mg tablets. The $1,811.22 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 12, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,564,840 units of Losartan Potassium 100 mg tablets. The contract has a ceiling value of $2,179.10 and a completion date of June 10, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMHVD, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,318.69, is for the delivery of 4,567,235,577 units of Losartan Potassium 50 mg tablets. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,016,626 units of Losartan Potassium 50 mg tablets. The contract has a ceiling value of $1,071.94 and a period of performance through March 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 with a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,796,057 units of Losartan Potassium 100mg tablets, valued at $1,877.22. It is a firm fixed-price delivery order contract with an ultimate completion date of April 4, 2025. This award is not associated with a set-aside designation. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,300.49, is a delivery order for the supply of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of March 26, 2025 and is a Firm Fixed Price contract. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCWAT
    Delivery Order

This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCWAT, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,985,206 units of Losartan Potassium 100 mg tablets in 1,000-count containers. The contract has a ceiling value of $3,024.43 and a completion date of April 22, 2025. It is a firm-fixed-price delivery order contract, without any set-aside designation.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/21/25, 7:36 PM